Verastem, Inc. Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value
Verastem, Inc. (VSTM) had Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value of $9.90 million as of 2017-12-31, per its 10-K filed 2018-03-13.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue · last filed 2018-03-13
- 2017-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $9.90M.
- 2017-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $2.50M.
- 2017-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $17.40M.
- 2016-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $23.60M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value |
|---|---|
| 2017-12-31 | $9.90M 10-K · filed 2018-03-13 |
| 2017-09-30 | $2.50M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $17.40M 10-Q · filed 2017-08-08 |
| 2016-12-31 | $23.60M 10-K · filed 2018-03-13 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-07 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-08 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-09 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-10 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 |
| 2014-09-30 | $0.00 10-Q · filed 2014-10-30 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-07 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-08 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-12 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-13 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |